Next Article in Journal
Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression
Next Article in Special Issue
Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing Cells
Previous Article in Journal / Special Issue
Aberrantly Over-Expressed TRPM8 Channels in Pancreatic Adenocarcinoma: Correlation with Tumor Size/Stage and Requirement for Cancer Cells Invasion
Cells 2014, 3(2), 517-545; doi:10.3390/cells3020517
Review

TRPV1: A Potential Drug Target for Treating Various Diseases

1,2
, 1
, 3
, 1,3
 and 1,*
Received: 27 March 2014; in revised form: 14 May 2014 / Accepted: 15 May 2014 / Published: 23 May 2014
(This article belongs to the Special Issue Transient Receptor Potential (TRP) Channels)
View Full-Text   |   Download PDF [657 KB, uploaded 23 May 2014]   |   Browse Figures
Abstract: Transient receptor potential vanilloid 1 (TRPV1) is an ion channel present on sensory neurons which is activated by heat, protons, capsaicin and a variety of endogenous lipids termed endovanilloids. As such, TRPV1 serves as a multimodal sensor of noxious stimuli which could trigger counteractive measures to avoid pain and injury. Activation of TRPV1 has been linked to chronic inflammatory pain conditions and peripheral neuropathy, as observed in diabetes. Expression of TRPV1 is also observed in non-neuronal sites such as the epithelium of bladder and lungs and in hair cells of the cochlea. At these sites, activation of TRPV1 has been implicated in the pathophysiology of diseases such as cystitis, asthma and hearing loss. Therefore, drugs which could modulate TRPV1 channel activity could be useful for the treatment of conditions ranging from chronic pain to hearing loss. This review describes the roles of TRPV1 in the normal physiology and pathophysiology of selected organs of the body and highlights how drugs targeting this channel could be important clinically.
Keywords: TRPV1; peripheral neuropathy; ototoxicity; diabetes; cystitis; obesity TRPV1; peripheral neuropathy; ototoxicity; diabetes; cystitis; obesity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Brito, R.; Sheth, S.; Mukherjea, D.; Rybak, L.P.; Ramkumar, V. TRPV1: A Potential Drug Target for Treating Various Diseases. Cells 2014, 3, 517-545.

AMA Style

Brito R, Sheth S, Mukherjea D, Rybak LP, Ramkumar V. TRPV1: A Potential Drug Target for Treating Various Diseases. Cells. 2014; 3(2):517-545.

Chicago/Turabian Style

Brito, Rafael; Sheth, Sandeep; Mukherjea, Debashree; Rybak, Leonard P.; Ramkumar, Vickram. 2014. "TRPV1: A Potential Drug Target for Treating Various Diseases." Cells 3, no. 2: 517-545.


Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert